Clinical Trials Browser

OTHER × Prostatic Neoplasms × Raloxifene Hydrochloride × Clear all

NCT01050842 2017-03-23

Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms